Two Sigma Investments’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.58M | Sell |
558,846
-203,207
| -27% | -$1.3M | 0.01% | 1414 |
|
|
2025
Q1 | $2.7M | Buy |
762,053
+110,536
| +17% | +$391K | 0.01% | 1504 |
|
|
2024
Q4 | $2.46M | Buy |
651,517
+284,280
| +77% | +$1.07M | 0.01% | 1523 |
|
|
2024
Q3 | $1.19M | Sell |
367,237
-930,601
| -72% | -$3.02M | ﹤0.01% | 1965 |
|
|
2024
Q2 | $2.47M | Sell |
1,297,838
-135,027
| -9% | -$257K | 0.01% | 1351 |
|
|
2024
Q1 | $4.07M | Buy |
1,432,865
+1,389,065
| +3,171% | +$3.94M | 0.01% | 1036 |
|
|
2023
Q4 | $645K | Buy |
+43,800
| New | +$645K | ﹤0.01% | 2248 |
|